More traditional VC investors were going later-stage in 2025, continuing a trend from the last two years
https://forbion.com/media/a3wjzegd/societe-generale-biotech-venture-capital-and-ipo-insights-2025-review-and-2026-outlook.pdf
-
https://s3.amazonaws.com/media.mediapost.com/uploads/DENTSU_GL1_February_2025.pdf
-
https://assets.contentstack.io/v3/assets/blt4eb669caa7dc65b2/blt79266ca5d3a390c1/Obesity_Drug_Market_Report.pdf
-
https://www.aranca.com/assets/docs/AI-Revolution-in-Drug-Industry-Transforming-R&D-and-Financial-Growth.pdf
